C61 E00-E07
Conditions
Interventions
Group 1: Molecular biological analysis of the blood samples obtained.
Changes in gene expression, the epigenome, and chromatin structure,
DNA damage response, and blood count are examined. Saliva samp
Sponsors
Universitätsklinikum Augsburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Written consent to participate in the study • Age > 18 years • Capacity to consent • Medically justified indication for the use of open radioactive substances by the attending physician
Exclusion criteria
Exclusion criteria: - Pregnant or breastfeeding women - Minors (< 18 years of age) and patients with mental illnesses - Patients who are unable to provide written consent to participate in the study. - Age < 18 years - Pregnancy - Lack of written consent from the patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of this in vivo project is to investigate whether various biological changes can also be detected in the context of radiation exposure during the use of open radioactive substances. This is done by taking saliva and blood samples. | — |
Countries
Germany
Contacts
Public ContactChristian Pfob
Universitätsklinikum Augsburg
Outcome results
None listed